Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative ...

According to The Daily Mail, Zach Stubbings —a former flight sergeant and helicopter winchman—was diagnosed with multiple ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

Supporting and encouraging breastfeeding can be an important milestone in maximising child health and reducing disease risk.

With Denison being a smaller university, the ability to have meaningful relationships with other students and professors can be much higher than at a larger school. Specifically, student-athletes are ...

Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

Zach Stubbings was diagnosed with multiple myeloma, cancer of the blood and bone marrow, in 2013, thirteen years after ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

A bright, colorful banner made of stapled-together pennants waves at the top of a small hill in the Myer family’s front yard ...

Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...